Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,683.60
Bid: 1,688.80
Ask: 1,689.60
Change: 35.00 (2.12%)
Spread: 0.80 (0.05%)
Open: 1,641.00
High: 1,693.20
Low: 1,641.00
Yest. Close: 1,648.60
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

GSK to update on potential cancer treatment at European congress

Wed, 12th Jun 2019 12:34

(Sharecast News) - GlaxoSmithKline is to present studies on a potential breakthrough cancer treatment at a major conference, the drugs giant confirmed on Wednesday.

GSK said new data on belantamab mafodotin, an investigational anti-BCMA antibody-drug conjugate being tested on patients with relapsed/refractory multiple myeloma, would be presented at this year's European Hematology Association Congress.

The treatment is not approved for use anywhere in the world. But in 2017 it was awarded breakthrough therapy designation by the US Food and Drug Administration and PRIME designation by the European Medicines Agency, and is undergoing clinical trials.

Research being presented at the EHA Congress includes patient reported experience as well as studies looking at the effectiveness of the treatment.

The UK's biggest drug company reported full-year sales of more than £30bn in February, but at the time warned that generic competition would hurt its blockbuster asthma treatment.

The blue chip is looking to strengthen its pipeline of new drugs, with a particular focus on immunology, genetics and new technologies. It is selling its consumer healthcare business, which includes brands such as Horlicks, to Unilever, and earlier this year said it had doubled the amount of oncology assets in clinical development to 16 since July 2018.

The 24th EHA Congress will be held in Amsterdam on 13 - 16 June.

More News

GSK to produce 1bn doses of vaccine boosters

(Sharecast News) - Pharmaceutical company GlaxoSmithKline announced it will produce 1bn doses of coronavirus vaccine booster in preparation for an eventual immunisation drive.

Today 11:06

Sanofi to sell stake in Covid-19 treatment maker Regeneron

(Sharecast News) - Sanofi will sell its stake in US-based maker of Covid-19 treatments Regeneron Pharmaceuticals.

26 May 20 11:59

Oxford University's push for Covid-19 vaccine may stumble due to drop in infections

(Sharecast News) - Oxford University's attempts to develop a vaccine against the novel coronavirus could run into an apparently unexpected hurdle, the head of its research team said.

26 May 20 11:53

Novavax begins trialling Covid-19 vaccine in Australia

(Sharecast News) - Biotechnology firm Novavax has begun trialling a Covid-19 vaccine candidate in Australia as it hopes to release a proven vaccine by the end of 2020.

26 May 20 11:11

GlaxoSmithKline hails HIV treatment breakthrough

(Sharecast News) - GlaxoSmithKline said on Monday that ViiV Healthcare, in which it owns a majority stake, is ending a study early after finding that its long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral pre-exposure prophylaxis (PrEP) in preventing HIV transmission.

18 May 20 07:40

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

14 May 20 09:19

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

7 May 20 16:27

UK DIRECTOR DEALINGS SUMMARY: ThinkSmart Non-Exec Buys 500,000 Shares

UK DIRECTOR DEALINGS SUMMARY: ThinkSmart Non-Exec Buys 500,000 Shares

7 May 20 16:13

GlaxoSmithKline divests of holding in Hindustan Unilever

(Sharecast News) - GlaxoSmithKline announced a rise in the proceeds it was expecting from the sale of its Indian consumer healthcare portfolio on Thursday, as it sold its holding in Hindustan Unilever.

7 May 20 09:28

GlaxoSmithKline's Hindustan Unilever Shares To Reap More Than Expected

GlaxoSmithKline's Hindustan Unilever Shares To Reap More Than Expected

7 May 20 09:23

Tuesday broker round-up

(Sharecast News) - Stagecoach Group: Canaccord upgrades to buy with a target price of 110p.

5 May 20 13:27

UK BROKER RATINGS SUMMARY: Bereneberg Prefers Brewins Over Rathbones

UK BROKER RATINGS SUMMARY: Bereneberg Prefers Brewins Over Rathbones

5 May 20 09:29

Monday broker round-up

(Sharecast News) - Go-Ahead Group: Canaccord upgrades to buy with a target price of 1,650p.

4 May 20 13:34

UK BROKER RATINGS SUMMARY: Buy Dixons Carphone And AG Barr - Liberum

UK BROKER RATINGS SUMMARY: Buy Dixons Carphone And AG Barr - Liberum

4 May 20 09:33

UK BROKER RATINGS SUMMARY: HSBC Cuts Shell Buts Raises Next

UK BROKER RATINGS SUMMARY: HSBC Cuts Shell Buts Raises Next

1 May 20 09:32

Login to your account

Don't have an account? Click here to register.